Therapeutic drug monitoring is predictive of loss of response after de-escalation of infliximab therapy in patients with inflammatory bowel disease in clinical remission
- Resource Type
- Article
- Source
- In
Clinics and Research in Hepatology and Gastroenterology February 2016 40(1):90-98 - Subject
- Language
- ISSN
- 2210-7401